We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Image: Triage Cardiac Panel is a rapid, POC fluorescence immunoassay used with Triage MeterPro (Photo courtesy of Quidel)

Quidel Triage Cardiac Panel Facilitates Rapid POC Diagnosis of Chest Pain Patients in ED

A point-of-care (POC), serial multi-marker testing strategy has been shown to facilitate the rapid diagnosis and management of chest pain patients in the emergency department (ED). Quidel Corporation (San Diego, CA, USA) has developed the Triage Cardiac Panel for use in the ED that is FDA cleared to aid in the diagnosis of myocardial infarction. More...
17 May 2022
Image: A wireless, bioelectronic pacifier could eliminate the need for invasive blood draws (Photo courtesy of WSU)

Smart Pacifier Eliminates Need for Invasive Blood Draws to Monitor Electrolytes of Babies in NICU

A wireless, bioelectronic pacifier could eliminate the need for invasive, twice-daily blood draws to monitor babies’ electrolytes in NICUs. More...
17 May 2022
Image: Resolute Onyx DES helps address all DES needs and numerous patient anatomies (Photo courtesy of Medtronic)

Medtronic’s Latest Generation Drug-Eluting Coronary Stent System Offers Dual-Layer Balloon Technology

The Onyx Frontier drug-eluting stent (DES) from Medtronic plc (Dublin, Ireland) for the treatment of patients with coronary artery disease (CAD) is the latest evolution in the company’s Resolute DES family that offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx DES. More...
17 May 2022
Image: Robotic surgery has been found to improve patient recovery time (Photo courtesy of Pexels)

Robotic Surgery Found to Be Safer, Reduces Patient Time in Hospital

Open surgery still remains the “gold standard” recommendation for highly complex surgeries Now, a first-of-its kind clinical trial provides the strongest evidence so far of the patient benefits of robot-assisted surgery. More...
16 May 2022
Image: The acquisition adds innovative bioabsorbable steroid-eluting sinus implants to Medtronic’s ENT portfolio (Photo courtesy of Intersect ENT)

Medtronic Completes Acquisition of Intersect ENT to Add Innovative Sinus Implants to ENT Portfolio

Medtronic plc (Dublin, Ireland) has completed the acquisition of Intersect ENT (Menlo Park, CA, USA), thereby expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps. More...
16 May 2022
Image: Smart stent can continuously monitor arterial pressure, pulse, and flow (Photo courtesy of Georgia Institute of Technology)

Smart Stent for Hemodynamics Monitoring Could Eliminate Need for Angiogram Imaging

A team of researchers is trying to improve treatments and outcomes for patients with vascular diseases by developing an implantable soft electronic monitoring system for the continuous monitoring of hemodynamics – blood flow through the vascular system. More...
13 May 2022
Image: Breakthrough tech enables seizure localization in minutes (Photo courtesy of Pexels)

Breakthrough Tech Pinpoints Seizure-Originating Brain Regions and Predicts Outcome Before Surgery

Researchers have introduced a novel network analysis technology that uses minimally invasive resting state electrophysiological recordings to localize seizure onset brain regions and predict seizure outcomes. More...
13 May 2022
Copyright © 2000-2022 Globetech Media. All rights reserved.